|
|
|
|
pmid:
|
Dawson MJ et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. |
1992 |
J. Antibiot. |
pmid:1624366
|
Sidebottom PJ et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation. |
1992 |
J. Antibiot. |
pmid:1624367
|
Baxter A et al. |
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. |
1992 |
J. Biol. Chem. |
pmid:1601846
|
Jones CA et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. III. Biosynthesis. |
1992 |
J. Antibiot. |
pmid:1429235
|
Gibbs JB et al. |
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. |
1993 |
J. Biol. Chem. |
pmid:8463291
|
Bergstrom JD et al. |
Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8419946
|
Hasumi K et al. |
Competitive inhibition of squalene synthetase by squalestatin 1. |
1993 |
J. Antibiot. |
pmid:8501015
|
Dufresne C et al. |
Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase. |
1993 |
J. Nat. Prod. |
pmid:8289063
|
Thelin A et al. |
Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids. |
1994 |
Biochim. Biophys. Acta |
pmid:7811707
|
Procopiou PA et al. |
The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues. |
1994 |
J. Med. Chem. |
pmid:7932554
|
Chen TS et al. |
The preparation of zaragozic acid A analogues by directed biosynthesis. |
1994 |
J. Antibiot. |
pmid:8002393
|
Correll CC and Edwards PA |
Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. |
1994 |
J. Biol. Chem. |
pmid:8276863
|
Biftu T et al. |
Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition. |
1994 |
J. Med. Chem. |
pmid:8308869
|
Ponpipom MM et al. |
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives. |
1994 |
J. Med. Chem. |
pmid:7966163
|
Bansal VS and Vaidya S |
Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes. |
1994 |
Arch. Biochem. Biophys. |
pmid:7986083
|
Ness GC et al. |
Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver. |
1994 |
Arch. Biochem. Biophys. |
pmid:8109970
|
Cannell RJ et al. |
Production of additional squalestatin analogues by directed biosynthesis. |
1994 |
J. Antibiot. |
pmid:8150722
|
Ness GC et al. |
Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase. |
1994 |
Arch. Biochem. Biophys. |
pmid:7911291
|
Kelly MJ and Roberts SM |
Synthetic chemistry. Combating cholesterol. |
1995 |
Nature |
pmid:7816124
|
Middleton RF et al. |
Novel squalestatins produced by biotransformation. |
1995 |
J. Antibiot. |
pmid:7775268
|
Bamford MJ et al. |
The squalestatins: synthesis and biological activity of some C3-modified analogues; replacement of a carboxylic acid or methyl ester with an isoelectronic heterocyclic functionality. |
1995 |
J. Med. Chem. |
pmid:7658437
|
Lindsey S and Harwood HJ |
Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation. |
1995 |
J. Biol. Chem. |
pmid:7721822
|
Doerner KC et al. |
Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures. |
1995 |
J. Lipid Res. |
pmid:7665995
|
Bergstrom JD et al. |
Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase. |
1995 |
Annu. Rev. Microbiol. |
pmid:8561474
|
Soltis DA et al. |
Expression, purification, and characterization of the human squalene synthase: use of yeast and baculoviral systems. |
1995 |
Arch. Biochem. Biophys. |
pmid:7864626
|
Fulton DC et al. |
Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatins. |
1995 |
Phytochemistry |
pmid:7766395
|
Crick DC et al. |
Selective inhibition of cholesterol biosynthesis in brain cells by squalestatin 1. |
1995 |
J. Neurochem. |
pmid:7643114
|
Procopiou PA et al. |
The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues. |
1996 |
J. Med. Chem. |
pmid:8691471
|
Ness GC et al. |
Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation. |
1996 |
Arch. Biochem. Biophys. |
pmid:8561503
|
Keller RK |
Squalene synthase inhibition alters metabolism of nonsterols in rat liver. |
1996 |
Biochim. Biophys. Acta |
pmid:8908150
|
Stankewich MC et al. |
Alterations in cell cholesterol content modulate Ca(2+)-induced tight junction assembly by MDCK cells. |
1996 |
Lipids |
pmid:8869884
|
Chan C et al. |
The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors. |
1996 |
J. Med. Chem. |
pmid:8568810
|
Keller RK et al. |
Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. |
1996 |
Arch. Biochem. Biophys. |
pmid:8645011
|
Corsini A et al. |
[Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells]. |
1997 |
C. R. Seances Soc. Biol. Fil. |
pmid:9255346
|
Onishi JC et al. |
Antimicrobial activity of viridiofungins. |
1997 |
J. Antibiot. |
pmid:9186560
|
Pirillo A et al. |
Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9070296
|
Bostedor RG et al. |
Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol. |
1997 |
J. Biol. Chem. |
pmid:9083051
|
Peffley DM and Gayen AK |
Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level. |
1997 |
Arch. Biochem. Biophys. |
pmid:9016820
|
Vlahcevic ZR et al. |
Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. |
1997 |
Gastroenterology |
pmid:9394735
|
Vaidya S et al. |
Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A. |
1998 |
Arch. Biochem. Biophys. |
pmid:9647670
|
Thompson JF et al. |
Truncation of human squalene synthase yields active, crystallizable protein. |
1998 |
Arch. Biochem. Biophys. |
pmid:9473303
|
Kocarek TA et al. |
Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver. |
1998 |
Mol. Pharmacol. |
pmid:9730906
|
Lopez D et al. |
Compensatory responses to inhibition of hepatic squalene synthase. |
1998 |
Arch. Biochem. Biophys. |
pmid:9514656
|
Petras SF et al. |
HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells. |
1999 |
J. Lipid Res. |
pmid:9869647
|
Michikawa M and Yanagisawa K |
Apolipoprotein E4 isoform-specific actions on neuronal cells in culture. |
1999 |
Mech. Ageing Dev. |
pmid:10360679
|
Gardner RG and Hampton RY |
A 'distributed degron' allows regulated entry into the ER degradation pathway. |
1999 |
EMBO J. |
pmid:10545111
|
Michikawa M and Yanagisawa K |
Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. |
1999 |
J. Neurochem. |
pmid:10349836
|
Hartmann MA et al. |
Metabolism of farnesyl diphosphate in tobacco BY-2 cells treated with squalestatin. |
2000 |
Biochem. Soc. Trans. |
pmid:11171211
|
Kaneshiro ES et al. |
Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817720
|